YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

    YiChang HEC ChangJiang Pharmaceutical Co., Ltd.

    HHKEX:1558
    15.88
    HKD
    0.00
    (0.00%)
    16.37P/E
    YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
    HKEX:1558
    (Hong Kong Exchange)

    Recent

    price

    15.88

    P/E

    ratio

    16.37

    div

    yld

    - -

    ROIC.AI

    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    CNY
    0.49
    1.03
    1.04
    1.77
    2.78
    7
    2.66
    1.04
    4.26
    7.15
    4.23
    Revenue per Share
    0.15
    0.4
    0.42
    0.72
    1.04
    2.16
    0.95
    -0.67
    0.09
    2.26
    0.55
    Basic EPS, GAAP
    0.1
    -0.05
    0.25
    0.33
    -0.42
    0.14
    -0.7
    -1.41
    0.96
    1.23
    -1.24
    Free Cash Flow per Basic Share
    - -
    - -
    0.08
    0.35
    0.35
    0.81
    0.25
    - -
    - -
    - -
    - -
    Dividend per Share
    0.19
    0.67
    0.5
    0.5
    0.5
    0.5
    1
    1
    3.35
    5.49
    6.03
    Book Value per Share
    0.21
    3.07
    2.73
    2.89
    3.43
    4.18
    2.63
    3.04
    3.45
    6.1
    6.82
    Tangible Book Value per Share
    901
    671
    902
    904
    904
    889
    881
    880
    880
    880
    880
    Basic Weighted Avg Shares
    441
    693
    942
    1,602
    2,510
    6,224
    2,348
    914
    3,745
    6,295
    3,724
    Sales/Revenue/Turnover
    41.77
    47.73
    44.78
    47.65
    43.16
    39.3
    18.86
    -48.24
    31.46
    45.72
    21.13
    Operating Margin (%)
    32
    26
    27
    44
    61
    86
    123
    260
    377
    391
    396
    Depreciation Expense
    135
    266
    381
    647
    943
    1,919
    839
    -588
    77
    1,993
    483
    Net Income, GAAP
    17.03
    15.56
    16
    16.28
    18.24
    15.95
    17.12
    - -
    - -
    12.74
    16.37
    Effective Tax Rate (%)
    30.7
    38.35
    40.42
    40.4
    37.54
    30.83
    35.75
    -64.31
    2.05
    31.66
    12.96
    Profit Margin (%)
    32
    1,539
    1,617
    1,428
    973
    3,019
    -897
    819
    73
    1,721
    2,193
    Working Capital
    145
    90
    20
    10
    - -
    2,903
    190
    3,145
    692
    289
    900
    LT Debt
    277
    2,143
    2,458
    3,061
    3,679
    4,623
    5,104
    6,021
    6,070
    7,936
    8,508
    Total Equity
    - -
    18.21
    14.3
    21.95
    25.11
    34.96
    4.57
    - -
    - -
    24.03
    6.07
    Return on Invested Capital (%)
    - -
    46.57
    65.18
    106.11
    133.55
    94.5
    26.76
    - -
    - -
    32.36
    7.53
    Return on Capital (%)
    - -
    85.52
    84.44
    143.35
    208.52
    425.98
    126.35
    -66.78
    4
    51.27
    9.52
    Return on Common Equity (%)

    Capital Structure

    CNY

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    CNY

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    82.51%
    13.43%
    7.22%
    Free Cash Flow
    -214.04%
    -170.09%
    -201.35%
    Net Income, GAAP
    244.5%
    417.23%
    -75.78%
    Sales/Revenue/Turnover
    58.15%
    42.74%
    -40.84%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    3,745
    2023
    - -
    - -
    - -
    - -
    6,295
    2024
    - -
    - -
    - -
    - -
    3,724

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    0.09
    2023
    - -
    - -
    - -
    - -
    2.26
    2024
    - -
    - -
    - -
    - -
    0.55

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business